Tyrosine kinase inhibitor (TKI) keratitis is an ocular complication of certain antineoplastic medications, primarily those that inhibit the epidermal growth factor receptor (EGFR). This activity will focus on the etiology, epidemiology, pathophysiology, clinical presentation, and management of TKI keratitis. It also highlights the role of the interprofessional team in managing patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/114091
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: All Practice Areas (e.g. ethics), Ambulatory/Outpatient, Complex General Surgical Oncology, General Operative Anesthesia, Hematology, Internal Medicine, Medical Oncology
Subscribe
Login
0 Comments
Oldest